Navigation Links
India to maintain Public domain Registry database of clinical trials conducted in India.

India to set up a registry database which will contain all datas and research results of all clinical trials which would be available in a public domain which will provide transparent results and information for patients.// The detail of the new registry database was announced by Drug Controller General of India Ashwani Kumar.

He announced the details of the registry during a two day workshop on 'Building and Managing Clinical Trial Capacity in India: Challenges in Ethics, Equity and Efficiency', which has been organized by Indian Council of Medical Research, Administrative Staff College of India and Fordham University, US. The workshop will discuss issues like prioritization of clinical trials, protection of vulnerable subjects, building ethical capacity, creating review mechanisms, reporting adverse events and accreditation and regulation.

The workshop was attended by more than 60 delegates including government officials, researchers, pharmaceutical companies' representatives, NGOs and advocacy groups are attending the workshop. It is being held in the backdrop of debates on methods employed in high-risk clinical trials by pharma firms and the concern on outsourcing of such trials to developing countries. The speakers at the inaugural session underlined the need for a strong legislative and regulatory framework for clinical trials and addressing ethical issues.

Experts View: Ashwani Kumar, Drug Controller General of India said, “Multi-centric clinical trials would be allowed on the same protocol as followed in the US and Britain, presently multinational companies were conducting 100 clinical trials in India while domestic firms were engaged in some 300 trials and he said training was being imparted to officials to supervise the process of clinical trials and ensure compliance with the regulations”.

Health secretary P. Hota said, “India had the potential and a great opportunity to emerge as a global centre for cl inical trials, we need to have the right kind of institutions, right legislation, and human skills and budgetary and other administrative support so that we don't miss the bus."

Falguni Sen, a professor at Fordham University, New York, said revenue accruing from clinical trials in India was $70 million in 2003. The Confederation of Indian Industry has estimated that this will grow to $200 million in 2007 and between $500 million and $1 billion by 2010.

Remarks: The Contract Research Organizations (CROs) found India an attractive destination, more than five CROs conducted 70 percent of the outsourced clinical trials worldwide, have established a presence in India directly or through partnerships. Though, we may be happy lot of clinical trials being conduced in India, but we should also be aware that clinical trials involving humans may be dangerous and it should not lead to exploring the poverty and ignorance of Indians involved in these clinical trials. So, a registry containing datas and results of clinical trials would be available to patients as well to committee monitoring it will help to avoid

Source: Indo-Asian News Servce
'"/>




Related medicine news :

1. Is Diabetes the Leading Cause of Kidney Failure in India
2. AIDS Disaster in India is Imminent
3. Indian Prime Minister has successful Knee Replacement Surgery
4. International community warns India on HIV situation
5. India takes on foot-and-mouth disease by vaccinating animals
6. Development of AIDS vaccine -- Chiron Corp in talks with four Indian cos
7. India to benefit from pharma companies move
8. Healthcare sector is now a multi billion-dollar industry in India
9. The World Bank funds private Hospital in India
10. Parke-Davis (India) runs into rough weather – Court orders attachment of asset
11. Indian Doctor granted US patent on organ regeneration
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/24/2017)... ... May 24, 2017 , ... The CFOs included on ... health systems in the nation and help their organizations navigate the challenges in ... been instrumental in developing successful hospital and health system strategy. , Becker's Hospital ...
(Date:5/23/2017)... ... May 23, 2017 , ... Axiad IDS , a ... CIO Applications magazine has named the company a “Top 25 Cybersecurity Companies 2017.” ... Cloud to help organizations simply and proactively address potential cybersecurity threats before they happen. ...
(Date:5/23/2017)... , ... May 23, 2017 , ... ... technology and a 2017 Best in KLAS category winner, has named Daniel P. ... to extend and enhance its technology platform and product offerings,” says Justin Neece, ...
(Date:5/23/2017)... ... May 23, 2017 , ... ... patients on peri-implantitis in Las Vegas, NV, and the importance of ... gum disease consultation and leading care for peri-implantitis, with or without a referral. ...
(Date:5/23/2017)... ... ... New patients with symptoms of gum disease in San Diego, ... treatments from the doctors at Art of Dentistry, without first receiving a referral. Drs. ... of receiving qualified treatment in order to avoid systemic health effects associated with untreated ...
Breaking Medicine News(10 mins):
(Date:5/10/2017)... 10, 2017 Radiology has become the number ... have also spiraled to the number one ranking as ... than ever before as the most complete and reliable ... with lower back pain an MRI may confirm a ... pain, resulting in entirely different treatment protocols.  In these ...
(Date:5/9/2017)... 2017  Oramed Pharmaceuticals Inc. (NASDAQ: ... company focused on the development of oral drug ... Property Office has granted Oramed a patent titled, ... The patent covers Oramed,s invention of an oral ... an incretin hormone that stimulates the secretion of ...
(Date:5/6/2017)... 2017   Provista , a proven leader in the ... today announced Jim Cunniff as the company,s new ... business experience to Provista, including most recently serving as the ... California . He assumed his new role with Provista ... fit for Provista," says Jody Hatcher , president, Sourcing ...
Breaking Medicine Technology: